Literature DB >> 30378436

A meta-analytic review of the relationship between neurocognition, metacognition and functional outcome in schizophrenia.

Geoff Davies1,2,3, Kathryn Greenwood1,2.   

Abstract

Previous research has identified that neurocognition predicts functional outcome in schizophrenia to a greater extent than psychopathology. More contemporary authors have begun to explore the role of metacognition as a mediating variable between neurocognition and functional outcome. The present review sought to extend the known work by synthesising the results reported in individual studies to see if these results are consistently found across samples. Relevant search strategies were entered into Medline (PubMed), PsychINFO and Embase. The present meta-analysis encompassed 17 studies (N = 1060) investigating the relationship between neurocognition and metacognition and seven studies investigating the relationship between metacognition and functional outcome (N = 645). A small-to-moderate mean effect size was found between neurocognition and metacognition (effect size range: 0.13-0.58) and a small-to-moderate effect size was found between metacognition and functional outcome (range: 0.17-0.57). Study findings suggest that relationships between variables are consistently found across samples and that future research should focus on investigating this relationship at earlier stages of illness, in female cohorts and across cognitive domains. Greater investigation is required in functional outcome, differentiating the impact of metacognition on functional capacity and other domains of functional outcome.

Entities:  

Keywords:  Schizophrenia; meta-analysis; metacognition; functional outcome; neurocognition; pychosis

Year:  2018        PMID: 30378436     DOI: 10.1080/09638237.2018.1521930

Source DB:  PubMed          Journal:  J Ment Health        ISSN: 0963-8237


  7 in total

1.  Brain Structural Correlates of Metacognition in First-Episode Psychosis.

Authors:  Erkan Alkan; Geoff Davies; Kathryn Greenwood; Simon L H Evans
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

2.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

3.  Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study.

Authors:  Paula Jhoana Escobedo-Aedo; Ana Forjan-González; Adela Sánchez-Escribano Martínez; Verónica González Ruiz-Ruano; Sergio Sánchez-Alonso; Laura Mata-Iturralde; Laura Muñoz-Lorenzo; Enrique Baca-García; Anthony S David; Javier-David Lopez-Morinigo
Journal:  Behav Sci (Basel)       Date:  2022-01-27

4.  Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition.

Authors:  Verónica Romero-Ferreiro; Lorena García-Fernández; Ana Isabel Aparicio; Isabel Martínez-Gras; Mónica Dompablo; Luis Sánchez-Pastor; David Rentero; Miguel Ángel Alvarez-Mon; Juan Manuel Espejo-Saavedra; Guillermo Lahera; Paloma Marí-Beffa; José Luis Santos; Roberto Rodriguez-Jimenez
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

5.  Real-World Functioning in Psychiatric Outpatients: Predictive Factors.

Authors:  Paola Bozzatello; Benedetta Giordano; Cristiana Montemagni; Paola Rocca; Silvio Bellino
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

6.  Efficacy of metacognitive training on symptom severity, neurocognition and social cognition in patients with schizophrenia: A single-blind randomized controlled trial.

Authors:  Zita Fekete; Edit Vass; Ramóna Balajthy; Ünige Tana; Attila Csaba Nagy; Barnabás Oláh; Nóra Domján; Ildikó Szabó Kuritárné
Journal:  Scand J Psychol       Date:  2022-04-06

7.  Cognitive and metacognitive factors predict engagement in employment in individuals with first episode psychosis.

Authors:  Abigail C Wright; Kim T Mueser; Susan R McGurk; David Fowler; Kathryn E Greenwood
Journal:  Schizophr Res Cogn       Date:  2019-05-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.